Ledger.Open graph →
SEC Form D · filed August 28, 2025

SISCAPA Assay Technologies, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Constance L. Seniff · Washington, Washington, D.C.Exec · DirectorTerry W. Pearson · Washington, Washington, D.C.DirectorNorman L. Anderson · Washington, Washington, D.C.Exec · DirectorGus W. Salem · Washington, Washington, D.C.DirectorConstance L. Seniff · Washington, Washington, D.C.Exec · DirectorTerry W. Pearson · Washington, Washington, D.C.DirectorNorman L. Anderson · Washington, Washington, D.C.Exec · DirectorGus W. Salem · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗